.jpg)
A comprehensive service to drug discovery clients including assay development, reagent testing and scale-up, proof of technology concept and validation, phenotypic screening and consultancy.
Acting as an intermediary between instrument and reagent manufacturers and prospective clients we can provide an expert lab-based environment for the validation of new technologies.
Cell-Based Screening
Cell based assays are of key importance at a number of stages in the drug discovery process. Being able to examine the interaction between your target and compounds in a cellular context is of great advantage in:
1. Mechanism of action studies
2. Identifying the potential for cytotoxicity
3. Defining the agonist or antagonist properties of your compounds
4. Distinguish compounds that can cross the membrane of cells for intracellular target interactions
The team at Aurelia Bioscience have developed and screened using cell-based assays for over 15 years. Our knowledge and skills in cell culture and manipulation, combined with our expertise in developing cell-based assays allow us to work rapidly and efficiently on the prosecution of your target in appropriate assays.
Our core technology platform enables us to measure readouts such as fluorescence, luminescence and chemi-luminescence. Example assays include but are not limited to:
1. Cytotoxicity measured using e.g. Resazurin, CellTiter-Glo, XTT
2. Second messenger and signal transduction assays e.g. cAMP accumulation, IP-one, b- arrestin activation
3. Reporter gene assays
4. Chemotaxis
5. Apoptosis
6. Cytokine release assays e.g. AlphaLisa
Ask us to use our experience to develop an assay to meet your needs…
Contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
